insulin sensitizers (Ember)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameinsulin sensitizers (Ember)
Drug Alias NamePPAR gamma modulators (Scripps Research Institute/Dana-Farber Cancer Institute)S-1664
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPeroxisome proliferator-activated receptor γ modulatorsInsulin sensitizers
TargetsPeroxisome proliferator-activated receptor γ
Therapy Area/IndicationsObesityDiabetes Mellitus, Type 2Diabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe Scripps Research Institute Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDana-Farber Cancer InstituteThe Scripps Research Institute IncEmber Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsObesityDiabetes Mellitus, Type 2Diabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A